Literature DB >> 33373328

Trk agonist drugs rescue noise-induced hidden hearing loss.

Katharine A Fernandez1,2, Takahisa Watabe1,2, Mingjie Tong1,2, Xiankai Meng1,2, Kohsuke Tani1,2, Sharon G Kujawa1,2,3, Albert Sb Edge1,2,3,4.   

Abstract

TrkB agonist drugs are shown here to have a significant effect on the regeneration of afferent cochlear synapses after noise-induced synaptopathy. The effects were consistent with regeneration of cochlear synapses that we observed in vitro after synaptic loss due to kainic acid-induced glutamate toxicity and were elicited by administration of TrkB agonists, amitriptyline, and 7,8-dihydroxyflavone, directly into the cochlea via the posterior semicircular canal 48 hours after exposure to noise. Synaptic counts at the inner hair cell and wave 1 amplitudes in the auditory brainstem response (ABR) were partially restored 2 weeks after drug treatment. Effects of amitriptyline on wave 1 amplitude and afferent auditory synapse numbers in noise-exposed ears after systemic (as opposed to local) delivery were profound and long-lasting; synapses in the treated animals remained intact 1 year after the treatment. However, the effect of systemically delivered amitriptyline on synaptic rescue was dependent on dose and the time window of administration: it was only effective when given before noise exposure at the highest injected dose. The long-lasting effect and the efficacy of postexposure treatment indicate a potential broad application for the treatment of synaptopathy, which often goes undetected until well after the original damaging exposures.

Entities:  

Keywords:  Neurodegeneration; Otology; Synapses

Year:  2021        PMID: 33373328      PMCID: PMC7934864          DOI: 10.1172/jci.insight.142572

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  39 in total

1.  Nonneuronal cells regulate synapse formation in the vestibular sensory epithelium via erbB-dependent BDNF expression.

Authors:  Maria E Gómez-Casati; Joshua C Murtie; Carlos Rio; Konstantina Stankovic; M Charles Liberman; Gabriel Corfas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

Review 2.  The molecular basis of neurosensory cell formation in ear development: a blueprint for hair cell and sensory neuron regeneration?

Authors:  Bernd Fritzsch; Kirk W Beisel; Laura A Hansen
Journal:  Bioessays       Date:  2006-12       Impact factor: 4.345

3.  Age-related cochlear synaptopathy: an early-onset contributor to auditory functional decline.

Authors:  Yevgeniya Sergeyenko; Kumud Lall; M Charles Liberman; Sharon G Kujawa
Journal:  J Neurosci       Date:  2013-08-21       Impact factor: 6.167

4.  Tricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain.

Authors:  D C U'Prichard; D A Greenberg; P P Sheehan; S H Snyder
Journal:  Science       Date:  1978-01-13       Impact factor: 47.728

5.  A physiological place-frequency map of the cochlea in the CBA/J mouse.

Authors:  Marcus Müller; Karen von Hünerbein; Silvi Hoidis; Jean W T Smolders
Journal:  Hear Res       Date:  2005-04       Impact factor: 3.208

6.  Lack of neurotrophin 3 causes losses of both classes of spiral ganglion neurons in the cochlea in a region-specific fashion.

Authors:  B Fritzsch; I Fariñas; L F Reichardt
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

7.  Patterns of neural degeneration in the human cochlea and auditory nerve: implications for cochlear implantation.

Authors:  J B Nadol
Journal:  Otolaryngol Head Neck Surg       Date:  1997-09       Impact factor: 3.497

Review 8.  The Trk A, B, C's of neurotrophins in the cochlea.

Authors:  Steven H Green; Erin Bailey; Qiong Wang; Robin L Davis
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

9.  Protection of spiral ganglion neurons from degeneration using small-molecule TrkB receptor agonists.

Authors:  Qing Yu; Qing Chang; Xia Liu; Yunfeng Wang; Huawei Li; Shusheng Gong; Keqiang Ye; Xi Lin
Journal:  J Neurosci       Date:  2013-08-07       Impact factor: 6.167

10.  Round-window delivery of neurotrophin 3 regenerates cochlear synapses after acoustic overexposure.

Authors:  Jun Suzuki; Gabriel Corfas; M Charles Liberman
Journal:  Sci Rep       Date:  2016-04-25       Impact factor: 4.379

View more
  5 in total

1.  A cell-type-specific atlas of the inner ear transcriptional response to acoustic trauma.

Authors:  Beatrice Milon; Eldad D Shulman; Kathy S So; Christopher R Cederroth; Erika L Lipford; Michal Sperber; Jonathan B Sellon; Heela Sarlus; Gabriela Pregernig; Benjamin Shuster; Yang Song; Sunayana Mitra; Joshua Orvis; Zachary Margulies; Yoko Ogawa; Christopher Shults; Didier A Depireux; Adam T Palermo; Barbara Canlon; Joe Burns; Ran Elkon; Ronna Hertzano
Journal:  Cell Rep       Date:  2021-09-28       Impact factor: 9.423

2.  Toward in vivo proof of binding of 18F-labeled inhibitor [18F]TRACK to peripheral tropomyosin receptor kinases.

Authors:  Melinda Wuest; Justin J Bailey; Jennifer Dufour; Darryl Glubrecht; Vanessa Omana; Tom H Johnston; Jonathan M Brotchie; Ralf Schirrmacher
Journal:  EJNMMI Res       Date:  2022-07-30       Impact factor: 3.434

Review 3.  Noise-Induced Hearing Loss: Updates on Molecular Targets and Potential Interventions.

Authors:  Huanyu Mao; Yan Chen
Journal:  Neural Plast       Date:  2021-07-06       Impact factor: 3.599

4.  A Novel Small Molecule Neurotrophin-3 Analogue Promotes Inner Ear Neurite Outgrowth and Synaptogenesis In vitro.

Authors:  Judith S Kempfle; Marlon V Duro; Andrea Zhang; Carolina D Amador; Richard Kuang; Ryan Lu; Boris A Kashemirov; Albert S Edge; Charles E McKenna; David H Jung
Journal:  Front Cell Neurosci       Date:  2021-07-15       Impact factor: 5.505

5.  Y-27632, a ROCK inhibitor, improved laser-induced shock wave (LISW)-induced cochlear synaptopathy in mice.

Authors:  Yutaka Koizumi; Kunio Mizutari; Satoko Kawauchi; Shunichi Sato; Akihiro Shiotani; Seiji Kakehata
Journal:  Mol Brain       Date:  2021-07-03       Impact factor: 4.041

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.